MUC16 and neoplasm: The binding of MSLN to MUC16 not only enhances the adhesion ability of tumor cells but also upregulates the expression of MMP7 through the PI3K/AKT signaling pathway, thereby strengthening the invasive capacity of these tumor cells.11